These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3753891)

  • 1. Acute myocardial necrosis during administration of amsacrine.
    Lindpaintner K; Lindpaintner LS; Wentworth M; Burns CP
    Cancer; 1986 Apr; 57(7):1284-6. PubMed ID: 3753891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amsacrine-associated cardiotoxicity: an analysis of 82 cases.
    Weiss RB; Grillo-López AJ; Marsoni S; Posada JG; Hess F; Ross BJ
    J Clin Oncol; 1986 Jun; 4(6):918-28. PubMed ID: 3519882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute electrocardiographic changes induced by amsacrine.
    Shinar E; Hasin Y
    Cancer Treat Rep; 1984 Sep; 68(9):1169-72. PubMed ID: 6592038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amsacrine in refractory acute leukemia.
    Griffin JD; Maguire ME; Mayer RJ
    Cancer Treat Rep; 1985; 69(7-8):787-9. PubMed ID: 3860296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amsacrine cardiotoxicity: assessment of ventricular function by radionuclide angiography.
    Vorobiof DA; Iturralde M; Falkson G
    Cancer Treat Rep; 1983 Dec; 67(12):1115-7. PubMed ID: 6689141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QT interval prolongation and cardiac dysrhythmia in a patient receiving amsacrine.
    Schwartz CL; Bender KS; Burke PJ; Kan JS; Civin CI
    Cancer Treat Rep; 1984; 68(7-8):1043-4. PubMed ID: 6547639
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypersensitivity reactions to amsacrine.
    Perry DJ; Weiss RB; Hoth DF
    Cancer Treat Rep; 1985 Feb; 69(2):199-201. PubMed ID: 3155993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMSA toxicity in patients with abnormal liver function.
    Mahal PS; Legha SS; Valdivieso M; Luna M; Benjamin RS; Bodey GP
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1343-8. PubMed ID: 6896030
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.
    Amrein PC; Richards F; Coleman M; Poulin RF; Holland JF; Weinberg V; Perry M
    Cancer Treat Rep; 1984 Jun; 68(6):923-4. PubMed ID: 6329510
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple ventricular extrasystoles following administration of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA).
    Falkson G
    Cancer Treat Rep; 1980; 64(2-3):358. PubMed ID: 6157470
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of acute myeloid leukemia with amsacrine and high-dose cytosine arabinoside: a phase II trial].
    Marit G; David B; Reiffers J; Broustet A
    Bull Cancer; 1985; 72(1):37-41. PubMed ID: 3857082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia.
    Arlin ZA
    Cancer Treat Rep; 1983 Nov; 67(11):967-70. PubMed ID: 6357436
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute ventricular fibrillation and death during infusion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA).
    Von Hoff DD; Elson D; Polk G; Coltman C
    Cancer Treat Rep; 1980; 64(2-3):356-8. PubMed ID: 6931630
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergic reaction following administration of AMSA.
    Rosenfelt FP; Rosenbloom BE; Weinstein IM
    Cancer Treat Rep; 1982 Mar; 66(3):594-5. PubMed ID: 6460556
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal hepatotoxicity associated with AMSA therapy.
    Appelbaum FR; Shulman HM
    Cancer Treat Rep; 1982 Oct; 66(10):1863-65. PubMed ID: 6957265
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
    Natale RB; Yagoda A; Blumenreich MS; Watson RC
    Cancer Treat Rep; 1983 Apr; 67(4):391-2. PubMed ID: 6687836
    [No Abstract]   [Full Text] [Related]  

  • 18. Amsacrine (AMSA)--a clinical review.
    Louie AC; Issell BF
    J Clin Oncol; 1985 Apr; 3(4):562-92. PubMed ID: 3884748
    [No Abstract]   [Full Text] [Related]  

  • 19. Electrocardiogram abnormalities induced by amsacrine.
    Weiss RB; Moquin D; Adams JD; Griffin JD; Zimbler H
    Cancer Chemother Pharmacol; 1983; 10(2):133-4. PubMed ID: 6572570
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II evaluation of amsacrine in colorectal, gastric, and pancreatic carcinomas: a Southeastern Cancer Study Group trial.
    Omura GA; Bartolucci AA; Lessner HE; Hill GJ
    Cancer Treat Rep; 1984 Jun; 68(6):929-30. PubMed ID: 6547369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.